Recombinant Human KRT19 protein, His&Myc-tagged

• Cat.No.: KRT19-2235H
• Product Overview: Recombinant Human KRT19 protein(P08727)(1-400aa), fused to N-terminal His tag and C-terminal Myc tag, was expressed in Insect Cell.

Specification

• Source: Insect Cell
• Species: Human
• Tag: His&Myc
• Form: If the delivery form is liquid, the default storage buffer is Tris/PBS-based buffer, 5%-50% glycerol.
  If the delivery form is lyophilized powder, the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, pH 8.0.
• Molecular Mass: 48 kDa
• Protein length: 1-400aa
• AA Sequence: MTSYSYRQSSATSSFGGLGGGSVRF GPGVAFRAPSIHGGSGGRGVSVSSA RFVSSSSSGAYGGGYGGVLTASDGL LAGNEKLTMQNLNDRLASYLDKVRA LEAANGELEVKIRDWYQKQGPGPSR DYSHYYTTIQDLRDKILGATIENSR IVLQIDNARLAADDFRTKFETEQAL RMSVEADINGLRRVLDELTLARTDL EMQIEGLKEELAYLKKNHEEEISTL RGQVGGQVSVEVDSAPGTDLAKILS DMRSQYEVMAEQNRKDAEAWFTSRT EELNREVAGHTEQLQMSRSEVTDLR RTLQGLEIELQSQLSMKAALEDTLA ETEARFGAQLAHIQALISGIEAQLG DVRADSERQNQEYQRLMDIKSRLEQ EIATYRSLLEGQEDHYNNLSASKVL
• Purity: Greater than 85% as determined by SDS-PAGE.
• Storage: Store at -20°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.
• Reconstitution: Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. Our default final concentration of glycerol is 50%. Customers could use it as reference.

Gene Information

• Gene Name: KRT19 keratin 19 [ Homo sapiens ]
• Official Symbol: KRT19
• Synonyms: KRT19; keratin 19; keratin, type I cytoskeletal 19; 40 kDa keratin intermediate filament; CK19; cytokeratin 19; K1CS; K19; keratin; type I cytoskeletal 19; type I; 40 kd; MGC15366; CK-19; keratin-19; cytokeratin-19; keratin, type I, 40-kd; 40-kDa keratin intermediate filament
• Gene ID: 3880
• mRNA Refseq: NM_002276
• Protein Refseq: NP_002267
• MIM: 148020
• UniProt ID: P08727

Reviews

08/25/2021

Such support helps researchers overcome challenges and obtain reliable results.

11/22/2020

This flexibility allows researchers to focus on specific aspects of KRT19 protein functionality, regulation, or disease associations, enhancing the relevance and applicability of their work.

08/26/2020

Manufacturers might offer customization options, such as different variants or modifications of the KRT19 protein, to cater to specific research requirements.

Q&As

Are there any clinical trials involving KRT19 protein?

Yes, there are ongoing clinical trials exploring the use of KRT19 as a biomarker and its potential as a therapeutic target in cancer treatment.

Are there any non-cancer clinical applications of KRT19?

Yes, KRT19 can also be used as a biomarker in other diseases, such as liver diseases and rheumatoid arthritis.

Are there any targeted therapies based on KRT19 expression?

Some targeted therapies are being developed that specifically target cancer cells with high KRT19 expression.

Can KRT19 protein be used to predict the prognosis of cancer patients?

Yes, KRT19 expression levels can provide information about the prognosis of cancer patients, helping in treatment planning.

How is KRT19 protein detected in clinical samples?

KRT19 protein can be detected using various laboratory techniques, including immunohistochemistry, ELISA, and PCR.